Bulletin from the Annual General Meeting in Oncopeptides AB (publ)
Stockholm, Sweden – 26 May 2020 – Oncopeptides AB (publ)’s (ONCO) Annual General Meeting 2020 was held today, at Tändstickspalatset in Stockholm. At the Annual General Meeting, the following principal resolutions were passed.· The presented annual report was adopted and the members of the Board of Directors and the CEO were discharged from liability in respect of the financial year 2019. · It was resolved to carry forward the result for the year in accordance with the Board of Directors’ proposal. · The proposed remunerations to the Board of Directors, its committees and the Company’s